Date | Opp | DKSAL | FDSAL | DKFPTS | FDFPTS | min | fg% | oreb | fga | ftm | dd | fta | tfoul | 3pm | usg | 3pa | 3p% | 2pm | fgm | 2pa | pfoul | reb | ffoul | ast | fouls | stl | pace | blk | ft% | to | 2p% | pts | td |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2019-06-13 | @ GSW | $1K | $6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2019-06-10 | vs. GSW | $1K | $6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2019-06-07 | @ GSW | $1K | $6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2019-06-05 | @ GSW | $1K | $6K | 0 | 0 | 0.85 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2019-06-02 | vs. GSW | $1K | $6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2019-05-30 | vs. GSW | $1.2K | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2019-05-25 | vs. MIL | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2019-05-23 | @ MIL | $1.2K | $6K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2019-05-21 | vs. MIL | $2.5K | $3.5K | 1.25 | 1.2 | 3.08 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 25.97 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
2019-05-19 | vs. MIL | $2.5K | $3.5K | 0 | 0 | 0.7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2019-05-17 | @ MIL | $2.5K | $3.5K | 7 | 7 | 8.28 | 0.4 | 0 | 5 | 0 | 0 | 0 | 0 | 1 | 28.99 | 2 | 0.5 | 1 | 2 | 3 | 1 | 0 | 0 | 0 | 1 | 1 | 6 | 0 | 0 | 1 | 0.33 | 5 | 0 |
2019-05-15 | @ MIL | $2.5K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2019-05-12 | vs. PHI | $2.5K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2019-05-09 | @ PHI | $2.5K | $3.5K | 4 | 5 | 3.55 | 0.5 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 22.54 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 0 | 0 | 0 | 1 | 2 | 0 |
2019-05-07 | vs. PHI | $2.5K | $3.5K | 3.5 | 3 | 6.78 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 5.9 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 3 | 0 |
2019-05-05 | @ PHI | $2.5K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2019-05-02 | @ PHI | $1K | $6K | 7.25 | 8.2 | 4.8 | 0.67 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 25 | 1 | 0 | 2 | 2 | 2 | 0 | 1 | 0 | 0 | 0 | 1 | 3 | 0 | 0 | 0 | 1 | 4 | 0 |
2019-04-29 | vs. PHI | $2.7K | $3.5K | -0.5 | -1 | 1.5 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 53.33 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 1 | 0 | 0 | 0 |
2019-04-27 | vs. PHI | -- | -- | 1.25 | 1.2 | 4.45 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 8.99 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
2019-04-23 | vs. ORL | $3K | $3.5K | 10.75 | 11.6 | 13.83 | 0.25 | 0 | 8 | 1 | 0 | 2 | 0 | 0 | 25.68 | 3 | 0 | 2 | 2 | 5 | 3 | 3 | 0 | 0 | 3 | 0 | 9 | 1 | 0.5 | 0 | 0.4 | 5 | 0 |
2019-04-21 | @ ORL | $3K | $3.5K | 2.5 | 2.4 | 5 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 8 | 0 | 0 | 0 | 0 | 1 | 0 | 2 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
2019-04-19 | @ ORL | $3K | $3.5K | 2 | 3 | 2.42 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2019-04-16 | vs. ORL | $3K | $3.5K | 0.75 | 0.2 | 8.47 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 18.89 | 3 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 4 | 0 | 0 | 1 | 0 | 0 | 0 |
2019-04-13 | vs. ORL | $3.1K | $3.5K | 4.5 | 4.5 | 2.77 | 0.5 | 0 | 2 | 1 | 0 | 1 | 0 | 0 | 40 | 0 | 0 | 1 | 1 | 2 | 0 | 0 | 0 | 1 | 0 | 0 | 2.5 | 0 | 1 | 0 | 0.5 | 3 | 0 |
2019-04-09 | @ MIN | $3.3K | $3.5K | 9.75 | 8.7 | 17.93 | 0.6 | 0 | 5 | 0 | 0 | 0 | 0 | 1 | 14.12 | 3 | 0.33 | 2 | 3 | 2 | 1 | 1 | 0 | 1 | 1 | 0 | 6 | 0 | 0 | 1 | 1 | 7 | 0 |
2019-04-07 | vs. MIA | $3.3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2019-04-05 | @ CHA | $3.3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2019-04-03 | @ BKN | $3.3K | $3.5K | 8.5 | 8 | 11.37 | 0.5 | 0 | 4 | 0 | 0 | 0 | 0 | 1 | 16.39 | 1 | 1 | 1 | 2 | 3 | 1 | 0 | 0 | 2 | 1 | 0 | 4 | 0 | 0 | 0 | 0.33 | 5 | 0 |
2019-04-01 | vs. ORL | $3.3K | $3.6K | 4.75 | 4.7 | 12 | 0.33 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 11.1 | 0 | 0 | 1 | 1 | 3 | 0 | 1 | 0 | 1 | 0 | 0 | 3 | 0 | 0 | 0 | 0.33 | 2 | 0 |
2019-03-30 | @ CHI | $3K | $3.5K | 22.75 | 22 | 28.88 | 0.67 | 1 | 9 | 0 | 0 | 0 | 0 | 2 | 13.85 | 4 | 0.5 | 4 | 6 | 5 | 0 | 5 | 0 | 0 | 0 | 1 | 9 | 0 | 0 | 1 | 0.8 | 14 | 0 |
2019-03-28 | @ NYK | $3K | $3.5K | 12.25 | 11.7 | 5 | 0.67 | 0 | 3 | 1 | 0 | 1 | 0 | 1 | 35.44 | 2 | 0.5 | 1 | 2 | 1 | 1 | 1 | 0 | 3 | 1 | 0 | 3.5 | 0 | 1 | 0 | 1 | 6 | 0 |
2019-03-26 | vs. CHI | -- | -- | 4 | 5 | 4.95 | 0.5 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 16.16 | 0 | 0 | 1 | 1 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 0 | 0.5 | 2 | 0 |
2019-03-01 | vs. POR | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2019-02-26 | vs. BOS | $3K | $3.5K | 9.5 | 8.9 | 7.15 | 0.5 | 0 | 4 | 0 | 0 | 0 | 0 | 1 | 24.22 | 3 | 0.33 | 1 | 2 | 1 | 1 | 2 | 0 | 1 | 1 | 0 | 4 | 0 | 0 | 0 | 1 | 5 | 0 |
2019-02-24 | vs. ORL | $3K | $3.5K | 13.5 | 12.4 | 16.75 | 0.44 | 0 | 9 | 0 | 0 | 0 | 0 | 2 | 21.49 | 5 | 0.4 | 2 | 4 | 4 | 1 | 2 | 0 | 0 | 1 | 0 | 9 | 0 | 0 | 0 | 0.5 | 10 | 0 |
2019-02-22 | vs. SAS | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2018-11-24 | vs. SAS | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2018-11-23 | vs. PHX | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2018-11-21 | vs. POR | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2018-11-19 | vs. DEN | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2018-11-16 | vs. CHI | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2018-11-14 | vs. MEM | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2018-11-11 | @ DEN | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2018-11-10 | @ LAC | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2018-11-08 | @ GSW | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2018-11-06 | @ POR | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2018-11-04 | vs. SAC | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2018-11-01 | @ BOS | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2018-10-29 | vs. TOR | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2018-10-27 | vs. ORL | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2018-10-26 | @ MIN | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2018-10-24 | vs. PHI | $3K | $3.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2018-10-22 | vs. NYK | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2018-10-19 | vs. IND | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2018-10-17 | @ CHA | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2018-04-11 | @ ORL | -- | -- | 24.5 | 21.9 | 19.12 | 0.43 | 0 | 14 | 1 | 0 | 2 | 0 | 5 | 31.82 | 10 | 0.5 | 1 | 6 | 4 | 3 | 2 | 0 | 1 | 3 | 0 | 15 | 0 | 0.5 | 0 | 0.25 | 18 | 0 |
2018-04-10 | vs. BOS | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2018-04-06 | vs. ATL | -- | -- | 6 | 5.5 | 9.85 | 0.5 | 0 | 2 | 1 | 0 | 2 | 0 | 1 | 13.04 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 3 | 0 | 0.5 | 0 | 0 | 4 | 0 |
2018-04-05 | @ CLE | -- | -- | 0 | 0 | 2.88 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2018-04-03 | @ HOU | -- | -- | 12.5 | 11.8 | 8.83 | 0.6 | 0 | 5 | 0 | 0 | 0 | 0 | 1 | 22.65 | 2 | 0.5 | 2 | 3 | 3 | 0 | 4 | 0 | 0 | 0 | 0 | 5 | 0 | 0 | 0 | 0.67 | 7 | 0 |
2018-04-01 | @ CHI | -- | -- | 14.25 | 12.1 | 18.58 | 0.75 | 0 | 4 | 1 | 0 | 1 | 0 | 2 | 14.57 | 3 | 0.67 | 1 | 3 | 1 | 0 | 3 | 0 | 1 | 0 | 0 | 6.5 | 0 | 1 | 2 | 1 | 9 | 0 |
2018-03-31 | vs. CHA | -- | -- | 2 | 3 | 1.73 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2018-03-29 | @ DET | -- | -- | 11.25 | 10.7 | 13.83 | 0.4 | 0 | 5 | 0 | 0 | 0 | 0 | 2 | 18.31 | 5 | 0.4 | 0 | 2 | 0 | 1 | 1 | 0 | 1 | 1 | 1 | 6 | 0 | 0 | 1 | 0 | 6 | 0 |
2018-03-27 | vs. SAS | -- | -- | 19.5 | 18.4 | 20.35 | 0.45 | 0 | 11 | 1 | 0 | 1 | 0 | 2 | 23.78 | 5 | 0.4 | 3 | 5 | 6 | 0 | 2 | 0 | 2 | 0 | 0 | 11.5 | 0 | 1 | 0 | 0.5 | 13 | 0 |
2018-03-25 | vs. NYK | -- | -- | 5.25 | 5.2 | 4.9 | 0.33 | 0 | 3 | 2 | 0 | 2 | 0 | 0 | 31.67 | 0 | 0 | 1 | 1 | 3 | 0 | 1 | 0 | 0 | 0 | 0 | 4 | 0 | 1 | 0 | 0.33 | 4 | 0 |
2018-03-23 | vs. DEN | -- | -- | 1.25 | 1.2 | 9.95 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 4.02 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
2018-03-21 | @ SAS | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2018-03-17 | vs. IND | -- | -- | 15.25 | 15.6 | 20.97 | 0.25 | 0 | 4 | 2 | 0 | 2 | 0 | 0 | 13.73 | 2 | 0 | 1 | 1 | 2 | 0 | 3 | 0 | 4 | 0 | 1 | 6 | 0 | 1 | 1 | 0.5 | 4 | 0 |
2018-03-14 | @ BOS | -- | -- | 11 | 10.4 | 12.12 | 0.43 | 0 | 7 | 1 | 0 | 2 | 0 | 1 | 26.01 | 4 | 0.25 | 2 | 3 | 3 | 0 | 2 | 0 | 0 | 0 | 0 | 8 | 0 | 0.5 | 0 | 0.67 | 8 | 0 |
2018-03-13 | vs. MIN | -- | -- | 9.25 | 8.2 | 14.12 | 0.67 | 0 | 3 | 0 | 0 | 0 | 0 | 1 | 13.2 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 0 | 2 | 1 | 0 | 4 | 0 | 0 | 1 | 0.5 | 5 | 0 |
2018-03-10 | @ MIA | -- | -- | 32 | 29.8 | 27.68 | 0.47 | 0 | 15 | 6 | 0 | 6 | 0 | 3 | 27.89 | 6 | 0.5 | 4 | 7 | 9 | 2 | 4 | 0 | 2 | 2 | 0 | 19 | 0 | 1 | 1 | 0.44 | 23 | 0 |
2018-03-09 | @ NOP | -- | -- | 19.5 | 19.3 | 21.23 | 0.5 | 1 | 8 | 0 | 0 | 0 | 0 | 2 | 15.69 | 3 | 0.67 | 2 | 4 | 5 | 0 | 4 | 0 | 1 | 0 | 1 | 7 | 0 | 0 | 0 | 0.4 | 10 | 0 |
2018-03-06 | vs. MIA | -- | -- | 2 | 2 | 10.17 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 3.93 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 2 | 0 |
2018-03-04 | vs. IND | -- | -- | 8.75 | 8.2 | 25.9 | 0.17 | 0 | 6 | 4 | 0 | 4 | 0 | 1 | 11.98 | 5 | 0.2 | 0 | 1 | 1 | 2 | 1 | 0 | 0 | 2 | 0 | 8 | 0 | 1 | 0 | 0 | 7 | 0 |
2018-03-02 | vs. TOR | -- | -- | 0 | 0 | 5.32 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 7.52 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
2018-02-28 | vs. GSW | -- | -- | 25.75 | 28.4 | 16.28 | 0.5 | 2 | 6 | 2 | 0 | 3 | 0 | 0 | 19.61 | 2 | 0 | 3 | 3 | 4 | 2 | 7 | 0 | 2 | 2 | 2 | 5.5 | 1 | 0.67 | 0 | 0.75 | 8 | 0 |
2018-02-27 | @ MIL | -- | -- | 8.5 | 8 | 16.38 | 0.6 | 0 | 5 | 1 | 0 | 2 | 0 | 1 | 14.36 | 2 | 0.5 | 2 | 3 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 0 | 0.5 | 0 | 0.67 | 8 | 0 |
2018-02-25 | vs. PHI | -- | -- | 11 | 10.9 | 10.67 | 0.4 | 0 | 5 | 0 | 0 | 0 | 0 | 1 | 23.73 | 2 | 0.5 | 1 | 2 | 3 | 0 | 2 | 0 | 1 | 0 | 1 | 6 | 0 | 0 | 1 | 0.33 | 5 | 0 |
2018-02-23 | vs. CHA | -- | -- | 4.5 | 3 | 8.02 | 0.33 | 0 | 3 | 2 | 0 | 2 | 0 | 1 | 29.33 | 3 | 0.33 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 0 | 1 | 2 | 0 | 5 | 0 |
2018-02-22 | @ CLE | -- | -- | 12.5 | 11.5 | 17.32 | 0.38 | 0 | 8 | 2 | 0 | 2 | 0 | 2 | 21.27 | 4 | 0.5 | 1 | 3 | 4 | 1 | 0 | 0 | 1 | 1 | 0 | 9 | 0 | 1 | 0 | 0.25 | 10 | 0 |
2018-02-14 | @ NYK | -- | -- | 17 | 17.9 | 13.35 | 1 | 0 | 2 | 4 | 0 | 4 | 0 | 0 | 14.23 | 0 | 0 | 2 | 2 | 2 | 1 | 2 | 0 | 3 | 1 | 1 | 4 | 0 | 1 | 0 | 1 | 8 | 0 |
2018-02-10 | @ CHI | -- | -- | 18 | 16.8 | 18.07 | 0.67 | 0 | 6 | 1 | 0 | 2 | 0 | 1 | 18.9 | 2 | 0.5 | 3 | 4 | 4 | 1 | 4 | 0 | 2 | 1 | 0 | 8 | 0 | 0.5 | 1 | 0.75 | 10 | 0 |
2018-02-08 | vs. BOS | -- | -- | 3.5 | 3.5 | 8.62 | 0 | 0 | 1 | 2 | 0 | 2 | 0 | 0 | 10.26 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 2 | 0 | 1 | 0 | 0 | 2 | 0 |
2018-02-06 | @ PHI | -- | -- | 1 | 0.5 | 4.75 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 36.46 | 2 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 4 | 0 | 0 | 1 | 0 | 0 | 0 |
2018-02-05 | @ IND | -- | -- | 15 | 13.5 | 11.78 | 0.67 | 0 | 6 | 0 | 0 | 0 | 0 | 2 | 27.13 | 4 | 0.5 | 2 | 4 | 2 | 0 | 0 | 0 | 3 | 0 | 0 | 7 | 0 | 0 | 1 | 1 | 10 | 0 |
2018-02-03 | @ ORL | -- | -- | 12.25 | 13.2 | 15.67 | 0.4 | 0 | 5 | 2 | 0 | 2 | 0 | 0 | 16.69 | 3 | 0 | 2 | 2 | 2 | 0 | 1 | 0 | 2 | 0 | 0 | 6 | 1 | 1 | 0 | 1 | 6 | 0 |
2018-02-01 | vs. TOR | -- | -- | 12.25 | 11.2 | 9.28 | 0.6 | 0 | 5 | 2 | 0 | 2 | 0 | 2 | 25.34 | 4 | 0.5 | 1 | 3 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 6 | 0 | 1 | 0 | 1 | 10 | 0 |
2018-01-30 | vs. OKC | -- | -- | 6 | 6.9 | 7.43 | 0 | 1 | 3 | 0 | 0 | 0 | 0 | 0 | 17.93 | 2 | 0 | 0 | 0 | 1 | 0 | 2 | 0 | 1 | 0 | 0 | 2 | 1 | 0 | 0 | 0 | 0 | 0 |
2018-01-27 | @ ATL | -- | -- | 14.75 | 14.6 | 9.87 | 0.5 | 1 | 6 | 0 | 0 | 0 | 0 | 2 | 24.32 | 4 | 0.5 | 1 | 3 | 2 | 0 | 3 | 0 | 0 | 0 | 1 | 5 | 0 | 0 | 0 | 0.5 | 8 | 0 |
2018-01-25 | @ OKC | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2018-01-22 | @ DAL | -- | -- | 8.25 | 7.2 | 12.02 | 0.43 | 0 | 7 | 0 | 0 | 0 | 0 | 1 | 26.62 | 4 | 0.25 | 2 | 3 | 3 | 0 | 1 | 0 | 0 | 0 | 0 | 8 | 0 | 0 | 1 | 0.67 | 7 | 0 |
2018-01-19 | @ DET | -- | -- | 11 | 12 | 7.6 | 0.6 | 0 | 5 | 0 | 0 | 0 | 0 | 0 | 29.79 | 2 | 0 | 3 | 3 | 3 | 0 | 0 | 0 | 2 | 0 | 1 | 5 | 0 | 0 | 0 | 1 | 6 | 0 |
2018-01-17 | @ CHA | -- | -- | 12.75 | 11 | 20.28 | 0.67 | 1 | 3 | 2 | 0 | 3 | 0 | 1 | 12.47 | 2 | 0.5 | 1 | 2 | 1 | 0 | 5 | 0 | 0 | 0 | 0 | 5.5 | 0 | 0.67 | 2 | 1 | 7 | 0 |
2018-01-15 | vs. MIL | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2018-01-13 | vs. BKN | -- | -- | 4.75 | 4.2 | 5.02 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 7.97 | 1 | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 3 | 0 |
2018-01-12 | vs. ORL | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
2018-01-10 | vs. UTA | -- | -- | 2.5 | 2.4 | 16.63 | 0 | 1 | 4 | 0 | 0 | 0 | 0 | 0 | 9.62 | 4 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 |
2018-01-06 | vs. MIL | -- | -- | 9.75 | 8.7 | 14.53 | 0.67 | 0 | 3 | 0 | 0 | 0 | 0 | 2 | 9.17 | 3 | 0.67 | 0 | 2 | 0 | 1 | 1 | 0 | 1 | 1 | 0 | 3 | 0 | 0 | 0 | 0 | 6 | 0 |
2018-01-05 | @ MEM | -- | -- | 1.5 | 1.5 | 8.85 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 15.05 | 2 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 |
2018-01-03 | vs. NYK | -- | -- | 9.75 | 9.6 | 12.13 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 10.95 | 1 | 0 | 0 | 0 | 1 | 0 | 3 | 0 | 4 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
2017-12-31 | vs. CHI | -- | -- | 3 | 3 | 3.08 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 27.27 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 2 | 1 | 0 | 1.5 | 0 | 0 | 0 | 0 | 0 | 0 |
2017-12-29 | vs. HOU | -- | -- | 22.25 | 19.5 | 17.97 | 0.5 | 0 | 8 | 2 | 0 | 3 | 0 | 3 | 30.38 | 6 | 0.5 | 1 | 4 | 2 | 0 | 5 | 0 | 1 | 0 | 1 | 13.5 | 0 | 0.67 | 4 | 0.5 | 13 | 0 |
2017-12-27 | @ ATL | -- | -- | 17.5 | 15.9 | 16.22 | 0.67 | 0 | 6 | 5 | 0 | 5 | 0 | 1 | 25.97 | 1 | 1 | 3 | 4 | 5 | 1 | 2 | 0 | 1 | 1 | 0 | 10.5 | 0 | 1 | 2 | 0.6 | 14 | 0 |
2017-12-25 | @ BOS | -- | -- | 2.75 | 2.7 | 8.15 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 16.34 | 2 | 0 | 0 | 0 | 1 | 2 | 1 | 0 | 1 | 2 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 |
2017-12-23 | vs. ORL | -- | -- | 20 | 18.7 | 19 | 0.33 | 1 | 9 | 2 | 0 | 2 | 0 | 2 | 21.49 | 5 | 0.4 | 1 | 3 | 4 | 2 | 6 | 0 | 1 | 2 | 0 | 9 | 0 | 1 | 0 | 0.25 | 10 | 0 |
2017-12-22 | @ BKN | -- | -- | 15 | 15.9 | 22.35 | 0.33 | 0 | 6 | 2 | 0 | 3 | 0 | 0 | 14.87 | 2 | 0 | 2 | 2 | 4 | 0 | 2 | 0 | 3 | 0 | 1 | 7.5 | 0 | 0.67 | 0 | 0.5 | 6 | 0 |
2017-12-19 | vs. NOP | -- | -- | 6.5 | 6 | 17.17 | 0.25 | 0 | 4 | 0 | 0 | 0 | 0 | 1 | 10.86 | 3 | 0.33 | 0 | 1 | 1 | 1 | 0 | 0 | 2 | 1 | 0 | 4 | 0 | 0 | 0 | 0 | 3 | 0 |
2017-12-17 | vs. CLE | -- | -- | 8.75 | 8.1 | 14.57 | 0.25 | 0 | 4 | 0 | 0 | 0 | 0 | 1 | 11.89 | 2 | 0.5 | 0 | 1 | 2 | 0 | 3 | 0 | 1 | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 3 | 0 |
2017-12-15 | vs. LAC | -- | -- | 1.75 | 0.7 | 18.52 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 11.51 | 3 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 0 | 5 | 0 | 0 | 2 | 0 | 0 | 0 |
2017-12-13 | vs. MEM | -- | -- | 17.75 | 17.9 | 18.92 | 0.29 | 1 | 7 | 0 | 0 | 0 | 0 | 1 | 15.5 | 4 | 0.25 | 1 | 2 | 3 | 2 | 7 | 0 | 1 | 2 | 1 | 6 | 0 | 0 | 0 | 0.33 | 5 | 0 |
2017-12-12 | @ BKN | -- | -- | 25.5 | 28.7 | 26.23 | 0.22 | 2 | 9 | 2 | 0 | 2 | 0 | 0 | 18.1 | 1 | 0 | 2 | 2 | 8 | 1 | 6 | 0 | 3 | 1 | 3 | 9 | 1 | 1 | 1 | 0.25 | 6 | 0 |
2017-12-09 | @ LAC | -- | -- | 3 | 3 | 7.68 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 13.85 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 2 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
2017-12-07 | @ PHX | -- | -- | 9.5 | 8.4 | 13.8 | 0.4 | 0 | 5 | 2 | 0 | 2 | 0 | 1 | 19.94 | 3 | 0.33 | 1 | 2 | 2 | 0 | 2 | 0 | 0 | 0 | 0 | 7 | 0 | 1 | 1 | 0.5 | 7 | 0 |
2017-12-05 | @ POR | -- | -- | 0.5 | 0 | 4.92 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 11.71 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.5 | 0 | 1 | 1 | 0 | 1 | 0 |
2017-12-04 | @ UTA | -- | -- | 7.5 | 6.9 | 22.08 | 0.22 | 1 | 9 | 0 | 0 | 0 | 0 | 0 | 18.71 | 3 | 0 | 2 | 2 | 6 | 2 | 2 | 0 | 1 | 2 | 0 | 9 | 0 | 0 | 1 | 0.33 | 4 | 0 |
2017-12-01 | vs. DET | -- | -- | 7.75 | 7.2 | 14.1 | 0.5 | 0 | 4 | 1 | 0 | 1 | 0 | 1 | 12.6 | 1 | 1 | 1 | 2 | 3 | 2 | 1 | 0 | 0 | 2 | 0 | 4.5 | 0 | 1 | 0 | 0.33 | 6 | 0 |
2017-11-29 | @ PHI | -- | -- | 31 | 30.3 | 26.45 | 0.45 | 1 | 11 | 8 | 0 | 9 | 0 | 3 | 23.12 | 6 | 0.5 | 2 | 5 | 5 | 5 | 4 | 0 | 1 | 5 | 1 | 14.5 | 0 | 0.89 | 0 | 0.4 | 21 | 0 |
2017-11-28 | @ MIN | -- | -- | 14 | 12 | 17.3 | 0.67 | 0 | 6 | 0 | 0 | 0 | 0 | 4 | 13.87 | 6 | 0.67 | 0 | 4 | 0 | 2 | 0 | 0 | 0 | 2 | 0 | 6 | 0 | 0 | 0 | 0 | 12 | 0 |
2017-11-25 | vs. POR | -- | -- | 5.5 | 5 | 18.18 | 0.4 | 0 | 5 | 2 | 0 | 2 | 0 | 0 | 15.14 | 1 | 0 | 2 | 2 | 4 | 1 | 0 | 0 | 0 | 1 | 0 | 7 | 0 | 1 | 1 | 0.5 | 6 | 0 |
2017-11-22 | @ CHA | -- | -- | 12 | 12 | 14.1 | 0.44 | 0 | 9 | 1 | 0 | 2 | 0 | 0 | 29.9 | 5 | 0 | 4 | 4 | 4 | 0 | 0 | 0 | 2 | 0 | 0 | 10 | 0 | 0.5 | 0 | 1 | 9 | 0 |
2017-11-20 | @ MIL | -- | -- | 10 | 9.9 | 19.22 | 0.5 | 0 | 4 | 2 | 0 | 3 | 0 | 0 | 11.76 | 1 | 0 | 2 | 2 | 3 | 2 | 2 | 0 | 1 | 2 | 0 | 5.5 | 0 | 0.67 | 0 | 0.67 | 6 | 0 |
2017-11-19 | @ TOR | -- | -- | 9.25 | 9.2 | 13.97 | 0 | 0 | 2 | 5 | 0 | 6 | 0 | 0 | 15.18 | 0 | 0 | 0 | 0 | 2 | 2 | 1 | 0 | 2 | 2 | 0 | 5 | 0 | 0.83 | 0 | 0 | 5 | 0 |
2017-11-17 | vs. MIA | -- | -- | 10 | 9 | 14.18 | 0.67 | 0 | 3 | 3 | 0 | 3 | 0 | 2 | 12.19 | 3 | 0.67 | 0 | 2 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 4.5 | 0 | 1 | 0 | 0 | 9 | 0 |
2017-11-15 | @ MIA | -- | -- | 8.75 | 9.2 | 15.73 | 0.67 | 0 | 3 | 2 | 0 | 2 | 0 | 0 | 12.41 | 1 | 0 | 2 | 2 | 2 | 1 | 1 | 0 | 0 | 1 | 1 | 5 | 0 | 1 | 1 | 1 | 6 | 0 |
2017-11-13 | vs. SAC | -- | -- | 5.25 | 5.2 | 14.85 | 0.25 | 0 | 8 | 0 | 0 | 0 | 0 | 0 | 21.55 | 4 | 0 | 2 | 2 | 4 | 0 | 1 | 0 | 0 | 0 | 0 | 8 | 0 | 0 | 0 | 0.5 | 4 | 0 |
2017-11-11 | vs. ATL | -- | -- | 17 | 18.4 | 20.37 | 0.43 | 1 | 7 | 0 | 0 | 0 | 0 | 2 | 15.71 | 5 | 0.4 | 1 | 3 | 2 | 0 | 2 | 0 | 0 | 0 | 3 | 7 | 0 | 0 | 1 | 0.5 | 8 | 0 |
2017-11-09 | vs. LAL | -- | -- | 5.25 | 6.2 | 17.87 | 0.2 | 0 | 5 | 0 | 0 | 0 | 0 | 0 | 11.19 | 2 | 0 | 1 | 1 | 3 | 2 | 1 | 0 | 0 | 2 | 1 | 5 | 0 | 0 | 0 | 0.33 | 2 | 0 |
2017-11-07 | vs. DAL | -- | -- | 8.5 | 7.5 | 13.48 | 0.17 | 0 | 6 | 4 | 0 | 4 | 0 | 1 | 26.97 | 4 | 0.25 | 0 | 1 | 2 | 2 | 0 | 0 | 1 | 2 | 0 | 9 | 0 | 1 | 1 | 0 | 7 | 0 |
2017-11-05 | @ TOR | -- | -- | 3.5 | 3 | 8.32 | 0.25 | 0 | 4 | 0 | 0 | 0 | 0 | 1 | 19.23 | 3 | 0.33 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 3 | 0 |
2017-11-03 | vs. CLE | -- | -- | 8 | 9 | 21.87 | 0.6 | 0 | 5 | 0 | 0 | 0 | 0 | 0 | 9.14 | 1 | 0 | 3 | 3 | 4 | 1 | 0 | 0 | 0 | 1 | 1 | 5 | 0 | 0 | 0 | 0.75 | 6 | 0 |
2017-11-01 | vs. PHX | -- | -- | 8.5 | 8 | 12.2 | 0.6 | 0 | 5 | 0 | 0 | 0 | 0 | 0 | 21.84 | 1 | 0 | 3 | 3 | 4 | 0 | 0 | 0 | 2 | 0 | 0 | 6 | 0 | 0 | 1 | 0.75 | 6 | 0 |
2017-10-29 | @ SAC | -- | -- | 18 | 16.8 | 20.5 | 0.27 | 1 | 11 | 3 | 0 | 4 | 0 | 2 | 28.8 | 7 | 0.29 | 1 | 3 | 4 | 0 | 4 | 0 | 0 | 0 | 1 | 14 | 0 | 0.75 | 2 | 0.25 | 11 | 0 |
2017-10-27 | @ GSW | -- | -- | 18.25 | 18.1 | 27.35 | 0.33 | 0 | 12 | 0 | 0 | 0 | 0 | 2 | 18.03 | 6 | 0.33 | 2 | 4 | 6 | 2 | 3 | 0 | 1 | 2 | 1 | 12 | 0 | 0 | 0 | 0.33 | 10 | 0 |
2017-10-25 | @ LAL | -- | -- | 20 | 21.4 | 15.95 | 0.6 | 0 | 5 | 3 | 0 | 4 | 0 | 2 | 19.46 | 4 | 0.5 | 1 | 3 | 1 | 1 | 2 | 0 | 0 | 1 | 3 | 8 | 0 | 0.75 | 1 | 1 | 11 | 0 |
2017-10-23 | @ DEN | -- | -- | 6.25 | 5.2 | 15.87 | 0.14 | 0 | 7 | 2 | 0 | 2 | 0 | 1 | 22.38 | 6 | 0.17 | 0 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 9 | 0 | 1 | 1 | 0 | 5 | 0 |
2017-10-20 | vs. DET | -- | -- | 12.75 | 12.2 | 15.03 | 0.4 | 0 | 5 | 3 | 0 | 3 | 0 | 2 | 19.48 | 3 | 0.67 | 0 | 2 | 2 | 0 | 1 | 0 | 0 | 0 | 1 | 7.5 | 0 | 1 | 1 | 0 | 9 | 0 |
2017-10-18 | vs. PHI | -- | -- | 19.05 | 11.5 | 3 | 8 | 7 | 0.33 | 7 | 0 | 1 | 0 | 2 | 1 | 2 | 0 | 6 | 0 | 1 | 0 | 0 | 0 | 23.27 | 0 | 0.38 | 0 | 0.5 | 14 | 0 | 0 |
Jodie Meeks Daily Fantasy News, Rankings, Projections
Jodie Meeks (illness) and Mike Scott (illness) available to play Friday
Meeks and Scott have both officially been cleared to play and will suit up for Friday's game against the Denver Nuggets after missing Wednesday's loss due to illnesses. Neither were given designations on the injury report at any point throughout the day, but their return to the lineup was ultimately expected, and their presence in the rotation will eat into the increased playing time of Kelly Oubre and Ramon Sessions, while Tim Frazier will likely be relegated from the rotation entirely. Meeks and Scott are considered key cogs in head coach Scott Brooks' rotation but given the number of minutes Oubre, Mahinmi, and the starters absorb, they rarely become relevant for daily fantasy formats when the Wizards are at, or near, full strength.
Jodie Meeks (illness) and Mike Scott (illness) ruled out Wednesday
Meeks and Scott didn't participate in shootaround Wednesday morning and both have officially been ruled out of tonight's game against the San Antonio Spurs after previously being listed as questionable on the Washington Wizards' injury report with flu-like symptoms. Meeks and Scott are both key cogs in the second unit, so their absences won't have any direct effect on head coach Scott Brooks' starting lineup, but Markieff Morris could see a nice boost in value given his already consistent minute role in the upper-20s to low-30s on a nightly basis. Conversely, Bradley Beal could also be the beneficiary of a few additional minutes considering the likelihood that Brooks would just tighten his rotation as much as possible and not allocate all of the vacated playing time to fringe rotational players. This would make Beal an intriguing tournament target on Wednesday's slate, but specifically on FanDuel, where he can be had at a sizable discount from his price tag on DraftKings.
Jodie Meeks (illness) and Mike Scott (illness) questionable Wednesday
Meeks and Scott didn't participate in shootaround Wednesday morning and both have been listed as questionable on the Washington Wizards' injury report for tonight's game against the San Antonio Spurs due to flu-like symptoms. Meeks and Scott are both key cogs in the second unit, so their potential absences wouldn't have any direct effect on head coach Scott Brooks' starting lineup, but Markieff Morris could see a nice boost in value if Scott is unavailable given his already consistent minute role in the upper-20s to low-30s on a nightly basis. Conversely, Bradley Beal could also be the beneficiary of a few additional minutes, if Meeks is ruled out, given the likelihood Brooks would just tighten his rotation as much as possible and not allocate all of the vacated playing time to fringe rotational players. This would make Beal an intriguing tournament target on Wednesday's slate, but specifically on FanDuel, where he can be had at a sizable discount from his price tag on DraftKings.
John Wall Questionable for Sunday
Washington Wizards superstar point guard John Wall suffered a shoulder injury late in Friday's loss to the Cleveland Cavaliers. Now listed with a questionable tag for Sunday's game vs. Toronto much of Wall's 20 points per game will fall into the hands of their other superstar Bradley Beal. First up to fill the minutes left by Wall will be backup point guard Tim Frazier, but it would not surprise me to see a player already in the rotation (Jodie Meeks) absorb some of those minutes as well. In Wall's post-game interview he stated that he probably should have come out of the game, thus creating a scenario where the Wizards could play it safe with their star player.
Evan Fournier (wrist) ruled OUT tonight for Magic
Fournier has been ruled out ahead of tonight's game with Nets. Jodie Meeks will start in his place. Terrence Ross will start but only play the first half. Since Orlando went out of their way to mention Fournier and Ross, we can hope this means Aaron Gordon, Elfrid Payton, and Nikola Vucevic will play a full game. Without question, there's a chance they don't, so they're probably too risky for cash. They are, however, very interesting tournament options. They're in an awesome matchup with the Nets, who are terrible against every position and allow the most fantasy points per game. Those three players have only played 86.4 minutes with Meeks alongside them when Ross and Fournier were out. Payton led in ppm, racking up 1.19 in FanDuel scoring. Gordon cam crashing down to earth last time out after posting monster double-doubles in back to back games. One of them was against Brooklyn; he had 22 points, 15 rebounds, and five assists. Vucevic scores an extra 0.05 FD ppm (1.22 total) when Fournier and Jeff Green are off the court this season. All three are solid tournament targets in this matchup, but they'll certainly be risky. Jodie Meeks doesn't have a huge ceiling and he's bombed in starts before, there are better value options available tonight.
C.J. Watson to replace the injured Jodie Meeks in the starting lineup
Watson will draw the start at shooting guard for tonight's game against the Milwaukee Bucks, replacing the injured Evan Fournier and Jodie Meeks, and the latter is expected to miss four to six weeks after spraining two ligaments in his right thumb in Wednesday's loss to the New Orleans Pelicans. Meeks had been starting in place of Fournier for the last three games, and with Fournier officially ruled out, Watson should be expected to handle a majority of the minutes at shooting guard. However, he is a volatile daily fantasy option that doesn't realistically possess an attainable ceiling. D.J. Augustin can also be expected to absorb some shooting guard minutes in addition to his normal backup point guard role. According to our CourtIQ tool, Augustin owns a positive 4.2% usage rate differential (25.6%) with Meeks and Fournier off the court this season. Augustin is an intriguing value play on tonight's slate, despite coming off the bench, and should see at least 25 minutes of action at or near the stone minimum across the industry.
Jodie Meeks (thumb) out 4-6 weeks
Meeks is expected to miss four to six weeks after spraining two ligaments in his right thumb in Wednesday's loss to the New Orleans Pelicans. Fortunately for him, the injury will not require surgery. Meeks had been starting in place of Evan Fournier for the last three games, and if Fournier is unable to suit up on Friday, Jeff Green or Mario Hezonja could draw the start at shooting guard. According to our CourtIQ tool, Green leads the Magic with a positive 4.5% usage rate differential (24.5%) with Meeks and Fournier off the court this season. Green could be an intriguing value option on Friday's slate against a Milwaukee squad that has consistently struggled with wing players all year long.
Evan Fournier (heel) ruled out; Jodie Meeks starts in his place again tonight
Fournier will not play in tonight's game against the New Orleans Pelicans after previously being listed as questionable on the Magic's injury report with a sore right foot that has now forced him to miss two consecutive games. Jodie Meeks will start at shooting guard in his place and has averaged approximately 35 minutes per game in Fournier's most recent injury stint, making him an elite punt option on Wednesday's slate. Additionally, Serge Ibaka owns a 2.6% usage rate differential (25.9%) with Fournier off the court this season.
Evan Fournier (foot) and Bismack Biyombo (knee) questionable for Wednesday
Evan Fournier missed Monday's game due to the injury and is being listed as questionable for Wednesday's game against the Pelicans. Jodie Meeks started in his place and made salary-based expectations in 33 minutes. If Meeks starts against the Pelicans, he should be able to return value once again. Bismack Biyombo is listed as questionable the Magic are hopeful he can play with a knee contusion. We should have another update after the Magic's shootaround tomorrow.
Evan Fournier (heel) ruled out; Jodie Meeks starts in his place again
Evan Fournier (heel) will miss another game and Jodie Meeks will garner another start. Meeks played 38 minutes in his most recent start and scored 24.6 FanDuel points against the Jazz. If he plays that many minutes again here today against the Nuggets, he should have much better game. Meeks' ownership will likely be high since Fournier was expected to be out.